Greece Crisis Fatig...
Services: Diversified Services
ProtoKinetix Inc. (PKTX: OTC)
$0.02 0.00 | 0.00%
02/08/12 - 03:48 PM ET
1.50K / 74.50K
Vol / Avg. Vol:0.01 / 0.02
Open / Prev. Close:0.01 - 0.02
Today's Range:0.01 - 0.07
52 Wk Range:0.00%
Performance YTD:TheStreet Rating:
Portfolios with PKTX
- Portfolio NameUser Type
Latest PKTX Headlines from TheStreet
Press Releases for PKTX
- Italian Laboratory Expands ProtoKinetix’ Market For AAGP™ - Business Wire 12.07.11 | 10:12 am
- ProtoKinetix Receives Excellent Results From The University Of British Columbia Eye Inflammation Study - Business Wire 09.21.11 | 07:09 am
- ProtoKinetix Launches Sales Of AAGP™ As A Tool To Protect Cells In Research - Business Wire 08.18.11 | 07:08 am
- The University Of British Columbia Studies The Development Of ProtoKinetix’ AAGP™ Anti-Inflammatory For The $20-Billion Eye Treatment Market - Business Wire 07.25.11 | 09:07 am
- ProtoKinetix Outlines AAGP™ Values In CEO Interview - Business Wire 06.09.11 | 07:06 am
- ProtoKinetix President And CEO To Be Interviewed Live - Business Wire 05.04.11 | 07:05 am
- ProtoKinetix Forms Joint Venture Partnership To Launch A Dermatitis Therapeutic Product For The Skin Care Industry - Business Wire 04.27.11 | 07:04 am
- ProtoKinetix AAGP™ Dramatically Increase Recovery Rate Of Cryopreserved And Refrigerated Stem Cells - Business Wire 03.16.11 | 07:03 am
- ProtoKinetix’ Lead Investigator And Scientific Advisor Published In Nature - Business Wire 03.08.11 | 07:03 am
- ProtoKinetix Funds Independent Confirmatory Trials - Business Wire 03.01.11 | 07:03 am
Partner Headlines for PKTX
